Discordance Between ApoB and LDL-C: A Cross-Sectional Analysis in a Multi-Ethnic Population
Samia Mora, James D. Otvos, Robert S. Rosenson, Paul M. Ridker · Cross-sectional cohort study
BlueRipple Assessment
This cross-sectional study of 6,814 participants from a multi-ethnic cohort examined the relationships and discordance between standard lipid parameters (LDL-C, non-HDL-C) and atherogenic particle number measures (apoB, LDL-P by NMR) across the full range of cardiometabolic risk profiles.
ApoB and LDL-P were highly correlated (r ≈ 0.85–0.90), effectively measuring the same thing by different methods. In contrast, LDL-C showed significant discordance with both apoB and LDL-P, particularly in individuals with metabolic syndrome, diabetes, or elevated triglycerides — exactly the populations where standard lipid panels are most commonly relied upon despite being most unreliable. In these patients, small dense LDL predominates, producing high particle number (high apoB) with relatively normal cholesterol concentration (normal LDL-C).
The clinical message is direct: in patients with insulin resistance — a large and growing share of the cardiovascular risk population — the standard lipid panel systematically underestimates atherogenic particle burden. ApoB measurement provides the accurate read. The study also confirms that apoB and NMR LDL-P are functionally interchangeable, supporting apoB as the simpler, cheaper clinical proxy for particle number.
We rate the evidence strong, with high clinical significance. A well-executed cross-sectional study from a diverse cohort confirming that apoB discordance with LDL-C is prevalent and clinically meaningful — particularly in the metabolically abnormal patients who most need accurate risk assessment.
The original source
Mora S, Otvos JD, Rosenson RS, Pradhan A, Buring JE, Ridker PM. J Clin Lipidol. 2018.
BlueRipple Health provides consumer education and research synthesis for informed health advocacy. This is not medical advice. Discuss all health decisions with a qualified clinician.